Cheng D, Kochar BD, Cai T, Ananthakrishnan AN, et al. Risk of Infections With Ustekinumab and Tofacitinib Compared to Tumor Necrosis Factor alpha Antagonists in Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2022;20:2366-2372.
PMID: 35066137